ONCY
Oncolytics Biotech Inc.
NASDAQ · Healthcare · Biotechnology · CA
$0.84
−1.55%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
619.6%
Return on equity
-498.1%
Return on assets
668.9%
Return on invested capital
0.00x
Asset turnover
-$28.9M
Cash from operations
$0.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026